Australian University Rankings Guide

Current Stem Cell Research and Therapy (ERA Journal)

Current Stem Cell Research and Therapy is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Current Stem Cell Research and Therapy issns are issn1: 1574-888X issn2: 2212-3946.

The fields covered by Current Stem Cell Research and Therapy as part of the evaluation of Australian university research excellence are:

Biochemistry and Cell Biology Research Rankings (Sub-Field)

Medical Biochemistry and Metabolomics Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Biochemistry and Cell Biology field include:

- Asian Journal of Biochemistry
- Cell Death and Disease
- Cells Tissues Organs: in vivo in vitro
- Cold Spring Harbor Laboratory: Symposia on Quantitative Biology
- Crystalline Materials
- DNA Repair
- EMBO Reports
- European Journal of Histochemistry
- FEBS Letters
- IET Systems Biology
- Integrative Biology: interdisciplinary approaches for molecular and cellular life sciences
- Journal fuer Mineralstoffwechsel: Zeitschrift fuer Physiologie Pathophysiologie und Klinik des Mineralstoffwechsels
- Journal of Integrated OMICS
- Neurochemistry International: the journal for the publication of cellular and molecular aspects of neurochemistry
- Progress in Molecular Biology and Translational Science


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4